• Consensus Rating: Hold
  • Consensus Price Target: $61.17
  • Forecasted Upside: 55.32%
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$39.38
▲ +2.88 (7.89%)

This chart shows the closing price for RPD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rapid7 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RPD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RPD

Analyst Price Target is $61.17
▲ +55.32% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for Rapid7 in the last 3 months. The average price target is $61.17, with a high forecast of $130.00 and a low forecast of $34.00. The average price target represents a 55.32% upside from the last price of $39.38.

This chart shows the closing price for RPD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 19 contributing investment analysts is to hold stock in Rapid7. This rating has held steady since September 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
8/7/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings
2/3/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 8 hold ratings
  • 0 sell ratings
5/4/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 8 hold ratings
  • 0 sell ratings
8/2/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 10 hold ratings
  • 0 sell ratings
10/31/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 10 hold ratings
  • 0 sell ratings
12/30/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 11 hold ratings
  • 0 sell ratings
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/24/2023JPMorgan Chase & Co.Initiated CoverageNeutral$38.00Low
1/12/2023DA DavidsonInitiated CoverageNeutral$34.00Low
1/5/2023Piper SandlerLower TargetOverweight$50.00 ➝ $45.00Low
1/4/2023BarclaysDowngradeOverweight ➝ Equal Weight$40.00 ➝ $37.00Low
12/19/2022Morgan StanleyLower TargetEqual Weight$55.00 ➝ $44.00Low
12/8/2022MizuhoLower TargetNeutral$45.00 ➝ $40.00Low
11/3/2022Wolfe ResearchDowngradeOutperform ➝ Market PerformLow
11/3/2022Raymond JamesLower TargetOutperform$85.00 ➝ $50.00Low
11/3/2022Royal Bank of CanadaLower TargetOutperform$57.00 ➝ $47.00Low
11/3/2022Canaccord Genuity GroupLower Target$60.00 ➝ $55.00Low
11/3/2022MizuhoDowngradeBuy ➝ Neutral$70.00 ➝ $45.00Low
11/3/2022Truist FinancialDowngradeBuy ➝ Hold$80.00 ➝ $40.00Low
11/3/2022BarclaysLower TargetOverweight$55.00 ➝ $40.00Low
10/27/2022Needham & Company LLCReiterated RatingHoldLow
10/24/2022Morgan StanleyLower TargetEqual Weight$80.00 ➝ $55.00Low
10/24/2022Royal Bank of CanadaLower TargetOutperform$85.00 ➝ $57.00Low
10/24/2022Truist FinancialLower TargetBuy$95.00 ➝ $80.00Low
10/24/2022KeyCorpLower TargetOverweight$86.00 ➝ $57.00Low
10/21/2022Needham & Company LLCDowngradeBuy ➝ HoldLow
10/20/2022Berenberg BankInitiated CoverageBuy ➝ Hold$44.00Low
10/19/2022Robert W. BairdReiterated RatingOutperform$90.00Low
10/17/2022MizuhoLower TargetBuy$85.00 ➝ $70.00Low
10/11/2022Canaccord Genuity GroupInitiated CoverageBuy$60.00Low
10/11/2022Canaccord Genuity GroupInitiated CoverageBuy$60.00Low
10/11/2022BarclaysLower Target$80.00 ➝ $55.00Low
9/23/2022BTIG ResearchInitiated CoverageNeutralLow
8/4/2022Raymond JamesBoost TargetOutperform$125.00 ➝ $130.00Low
8/4/2022Morgan StanleyLower TargetEqual Weight$95.00 ➝ $80.00N/A
8/4/2022MizuhoLower TargetBuy$95.00 ➝ $85.00N/A
8/4/2022Needham & Company LLCLower TargetBuy$155.00 ➝ $90.00Low
8/4/2022CitigroupLower Target$80.00 ➝ $78.00Low
8/1/2022Royal Bank of CanadaLower TargetOutperform$140.00 ➝ $85.00Low
7/22/2022KeyCorpLower TargetOverweight$129.00 ➝ $92.00Low
7/19/2022MizuhoLower TargetBuy$110.00 ➝ $95.00Low
7/13/2022Piper SandlerLower Target$120.00 ➝ $95.00N/A
7/12/2022BarclaysLower TargetOverweight$110.00 ➝ $92.00N/A
5/10/2022Truist FinancialLower Target$135.00 ➝ $110.00High
5/5/2022William BlairReiterated RatingOutperformHigh
5/5/2022MizuhoLower Target$135.00 ➝ $110.00High
5/5/2022Piper SandlerLower Target$140.00 ➝ $120.00High
4/12/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral$130.00High
4/11/2022Wolfe ResearchInitiated CoverageOutperform$122.00High
2/10/2022Royal Bank of CanadaBoost Target$130.00 ➝ $140.00Low
2/10/2022BarclaysBoost TargetOverweight$120.00 ➝ $122.00Low
2/10/2022KeyCorpBoost TargetOverweight$126.00 ➝ $129.00Low
2/7/2022Royal Bank of CanadaLower TargetOutperform$157.00 ➝ $130.00Low
2/2/2022KeyCorpLower TargetOverweight$162.00 ➝ $126.00Low
1/24/2022CitigroupInitiated CoverageNeutral$105.00High
1/19/2022BarclaysLower Target$141.00 ➝ $120.00Medium
1/18/2022Morgan StanleyLower TargetEqual Weight$106.00 ➝ $103.00Low
1/18/2022MizuhoLower Target$155.00 ➝ $135.00High
12/3/2021MizuhoReiterated RatingBuy$154.00N/A
11/4/2021Morgan StanleyBoost TargetEqual Weight$97.00 ➝ $106.00High
11/4/2021Stifel NicolausBoost TargetBuy$140.00 ➝ $160.00High
11/4/2021MizuhoBoost TargetBuy$138.00 ➝ $155.00High
11/4/2021Needham & Company LLCBoost TargetBuy$140.00 ➝ $155.00High
11/4/2021Raymond JamesBoost TargetOutperform$130.00 ➝ $145.00High
11/4/2021BarclaysBoost TargetOverweight$130.00 ➝ $141.00Medium
11/4/2021KeyCorpBoost TargetOverweight$141.00 ➝ $162.00Medium
11/4/2021Piper SandlerBoost TargetOverweight$130.00 ➝ $145.00Medium
11/1/2021Royal Bank of CanadaBoost TargetPositive ➝ Outperform$138.00 ➝ $150.00High
10/18/2021MizuhoBoost TargetBuy$125.00 ➝ $138.00High
9/23/2021FBN SecuritiesInitiated CoverageOutperform$140.00Medium
9/13/2021The Goldman Sachs GroupBoost TargetBuy$130.00 ➝ $140.00Low
8/6/2021The Goldman Sachs GroupBoost TargetBuy$114.00 ➝ $130.00Low
8/5/2021Truist FinancialBoost TargetBuy$110.00 ➝ $125.00Medium
8/5/2021Morgan StanleyBoost TargetEqual Weight$94.00 ➝ $97.00Low
8/5/2021Needham & Company LLCBoost TargetPositive ➝ Buy$130.00 ➝ $140.00High
8/5/2021Raymond JamesBoost TargetOutperform$105.00 ➝ $130.00High
8/5/2021Royal Bank of CanadaBoost TargetOutperform$120.00 ➝ $138.00High
8/5/2021Robert W. BairdBoost TargetOutperform$95.00 ➝ $130.00High
8/5/2021BarclaysBoost TargetOverweight$115.00 ➝ $130.00High
8/5/2021MizuhoBoost TargetBuy$110.00 ➝ $125.00High
8/2/2021KeyCorpInitiated CoverageOverweight$135.00Medium
7/20/2021Needham & Company LLCInitiated CoverageBuy$130.00High
7/20/2021Truist FinancialBoost TargetPositive ➝ Buy$95.00 ➝ $110.00High
7/20/2021Royal Bank of CanadaBoost TargetPositive ➝ Outperform$110.00 ➝ $120.00High
7/16/2021MizuhoBoost TargetHold ➝ Buy$92.00 ➝ $110.00Low
7/15/2021BarclaysBoost TargetOverweight$104.00 ➝ $115.00Medium
7/14/2021Needham & Company LLCBoost TargetBuy$110.00 ➝ $130.00Low
7/9/2021Piper SandlerBoost TargetOverweight$100.00 ➝ $110.00Medium
5/7/2021Raymond JamesBoost TargetOutperform$100.00 ➝ $105.00High
5/7/2021MizuhoLower TargetBuy$102.00 ➝ $92.00Low
3/8/2021Piper SandlerUpgradeNeutral ➝ Overweight$100.00N/A
3/2/2021Piper SandlerUpgradeNeutral ➝ Overweight$95.00 ➝ $100.00Low
2/17/2021Stifel NicolausInitiated CoverageBuyHigh
2/10/2021Morgan StanleyBoost TargetEqual Weight$86.00 ➝ $94.00Low
2/10/2021Needham & Company LLCBoost TargetBuy$82.00 ➝ $110.00Low
2/10/2021Raymond JamesBoost TargetOutperform$72.00 ➝ $100.00Low
2/10/2021Royal Bank of CanadaBoost TargetOutperform$105.00 ➝ $110.00Low
1/27/2021Truist FinancialBoost Target$72.00 ➝ $95.00High
1/22/2021Royal Bank of CanadaBoost TargetPositive ➝ Outperform$77.00 ➝ $105.00Medium
1/19/2021Monness Crespi & HardtBoost TargetBuy$77.00 ➝ $100.00High
1/12/2021MizuhoBoost TargetBuy$80.00 ➝ $102.00Low
1/8/2021Morgan StanleyBoost TargetEqual Weight$71.00 ➝ $86.00Low
1/6/2021BarclaysBoost TargetOverweight$77.00 ➝ $101.00N/A
1/4/2021Piper SandlerDowngradeOverweight ➝ Neutral$95.00N/A
11/5/2020Royal Bank of CanadaBoost TargetOutperform$70.00 ➝ $77.00High
11/5/2020Raymond JamesBoost TargetOutperform$70.00 ➝ $72.00High
11/5/2020Morgan StanleyBoost TargetEqual Weight$60.00 ➝ $61.00High
11/5/2020Needham & Company LLCBoost TargetBuy$72.00 ➝ $82.00High
11/5/2020Monness Crespi & HardtBoost TargetBuy$70.00 ➝ $77.00High
11/5/2020MizuhoBoost TargetBuy$75.00 ➝ $80.00High
11/5/2020BarclaysBoost TargetOverweight$70.00 ➝ $77.00High
10/15/2020MizuhoBoost TargetBuy$70.00 ➝ $75.00Medium
9/9/2020Morgan StanleyBoost TargetEqual Weight$55.00 ➝ $60.00Low
8/7/2020Needham & Company LLCReiterated RatingBuy$72.00Medium
8/7/2020Monness Crespi & HardtBoost TargetBuy$60.00 ➝ $70.00High
8/7/2020Raymond JamesBoost TargetStrong-Buy$64.00 ➝ $70.00High
8/7/2020MizuhoBoost TargetBuy$60.00 ➝ $70.00High
8/7/2020Piper SandlerBoost TargetOverweight$60.00 ➝ $75.00High
8/7/2020Robert W. BairdReiterated RatingBuyHigh
7/20/2020BarclaysBoost TargetOverweight$58.00 ➝ $65.00High
5/13/2020Morgan StanleyBoost TargetEqual Weight$43.00 ➝ $50.00Medium
5/10/2020Royal Bank of CanadaReiterated RatingBuy$65.00Medium
5/8/2020Raymond JamesBoost TargetStrong-Buy$53.00 ➝ $64.00Medium
5/8/2020MizuhoBoost TargetBuy$50.00 ➝ $53.00High
5/8/2020Robert W. BairdReiterated RatingBuyMedium
5/4/2020BarclaysLower TargetOverweight$51.00 ➝ $49.00Medium
4/30/2020MizuhoLower TargetBuy$52.00 ➝ $50.00Low
4/29/2020Monness Crespi & HardtLower TargetBuy$72.00 ➝ $60.00High
4/21/2020CowenLower TargetOutperform$70.00 ➝ $55.00Low
4/3/2020Raymond JamesLower TargetStrong-Buy$72.00 ➝ $53.00High
3/25/2020Morgan StanleyLower TargetEqual Weight$60.00 ➝ $43.00Medium
3/24/2020The Goldman Sachs GroupInitiated CoverageBuy$49.00Medium
3/18/2020Royal Bank of CanadaReiterated RatingBuy$65.00Medium
2/11/2020MizuhoReiterated RatingBuy$68.00Medium
2/11/2020Raymond JamesLower TargetStrong-Buy$75.00 ➝ $72.00High
2/11/2020Robert W. BairdReiterated RatingBuy$72.00High
1/22/2020Raymond JamesBoost TargetStrong-Buy$69.00 ➝ $75.00Low
12/9/2019Piper Jaffray CompaniesInitiated CoverageOverweight$67.00Low
11/5/2019Needham & Company LLCReiterated RatingBuy$72.00High
11/5/2019Robert W. BairdReiterated RatingBuy$72.00High
10/8/2019Robert W. BairdSet TargetBuy$72.00Low
10/2/2019SunTrust BanksInitiated CoverageBuy$66.00High
9/15/2019Robert W. BairdSet TargetBuy$72.00Medium
8/2/2019Morgan StanleyBoost TargetEqual Weight$51.00 ➝ $61.00Low
7/29/2019Needham & Company LLCBoost TargetBuy$60.00 ➝ $72.00High
7/29/2019Royal Bank of CanadaBoost TargetPositive ➝ Outperform$70.00High
7/29/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$62.00 ➝ $72.00High
7/18/2019BarclaysReiterated RatingBuy$69.00Low
7/15/2019Northland SecuritiesSet TargetBuy$75.00Low
6/28/2019Nomura SecuritiesInitiated CoverageBuy ➝ Buy$70.00 ➝ $70.00High
5/23/2019CowenInitiated CoverageOutperform ➝ Outperform$63.00Medium
5/6/2019DA DavidsonBoost TargetNeutral$52.00High
5/3/2019Morgan StanleySet TargetHold$53.00Low
5/3/2019BTIG ResearchBoost TargetBuy ➝ Positive$62.00High
5/3/2019Northland SecuritiesReiterated RatingBuy$64.00High
4/29/2019Needham & Company LLCBoost TargetBuy ➝ Buy$50.00 ➝ $60.00Low
4/15/2019KeyCorpBoost TargetOverweight ➝ Overweight$50.00 ➝ $60.00Low
4/12/2019BarclaysBoost TargetOverweight$48.00 ➝ $61.00Low
4/3/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$58.00High
4/3/2019Stifel NicolausBoost TargetBuy ➝ Buy$52.00 ➝ $58.00Low
3/26/2019MizuhoInitiated CoverageBuy ➝ Buy$59.00High
3/11/2019MacquarieUpgradeNeutral ➝ OutperformHigh
2/8/2019Morgan StanleySet TargetHold$42.00Medium
2/8/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$42.00 ➝ $50.00High
2/8/2019DA DavidsonBoost TargetNeutral$40.00High
2/8/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$41.00 ➝ $49.00High
1/29/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$39.00 ➝ $45.00Low
1/15/2019BTIG ResearchUpgradeNeutral ➝ Buy$42.00High
11/29/2018Berenberg BankInitiated CoverageBuy ➝ Buy$41.00Low
11/7/2018Morgan StanleySet TargetHold$35.00High
11/7/2018Monness Crespi & HardtBoost TargetBuy$38.00 ➝ $41.00High
10/2/2018Stifel NicolausBoost TargetBuy ➝ Buy$42.00 ➝ $44.00Low
9/21/2018Needham & Company LLCBoost TargetBuy ➝ Buy$37.00 ➝ $42.00Low
8/7/2018Monness Crespi & HardtBoost TargetBuy$35.00 ➝ $38.00High
8/7/2018KeyCorpBoost TargetOverweight ➝ Overweight$35.00 ➝ $38.00High
8/7/2018Stifel NicolausBoost TargetBuy ➝ Buy$36.00 ➝ $42.00High
8/7/2018Royal Bank of CanadaReiterated RatingBuy$40.00High
6/18/2018BTIG ResearchDowngradeBuy ➝ NeutralMedium
5/10/2018Rosenblatt SecuritiesReiterated RatingBuy$37.00Low
5/10/2018Needham & Company LLCBoost TargetBuy ➝ Buy$33.00 ➝ $37.00Low
5/10/2018BarclaysReiterated RatingBuy$36.00Low
5/9/2018Stifel NicolausBoost TargetBuy ➝ Buy$32.00 ➝ $36.00Medium
5/9/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$23.00 ➝ $30.00Medium
5/9/2018KeyCorpBoost TargetOverweight ➝ Overweight$30.00 ➝ $35.00Medium
5/4/2018Monness Crespi & HardtBoost TargetBuy ➝ Buy$27.00 ➝ $33.00High
4/20/2018CowenReiterated RatingBuy$30.00Medium
4/13/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$34.00High
4/10/2018DA DavidsonInitiated CoverageNeutral ➝ Neutral$28.00Low
2/28/2018Stifel NicolausInitiated CoverageBuy ➝ Buy$32.00High
2/13/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $23.00Low
2/13/2018Monness Crespi & HardtReiterated RatingBuy ➝ Buy$23.00 ➝ $27.00Low
2/12/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$23.00 ➝ $30.00Low
1/30/2018KeyCorpReiterated RatingOverweight ➝ Overweight$25.00 ➝ $30.00Low
(Data available from 1/29/2018 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
8/2/2022
  • 3 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/1/2022
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
10/1/2022
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2022
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/30/2022
  • 4 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
12/30/2022
  • 7 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
1/29/2023

Current Sentiment

  • 7 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Rapid7 logo
Rapid7, Inc. engages in the provision of cyber security analytics and automation services. Its products include Metasploit, Nexpose, AppSpider, tCell by Rapid7, as well as insight platforms such as InsightDR, InsightIVM, InsightAppSec, InsightConnect, and InsightOps. The firm also offers security and product consulting services. The company was founded by Alan P. Matthews, Tas Giakouminakis, and Chad Loder in July 2000 and is headquartered in Boston, MA.
Read More

Today's Range

Now: $39.38
Low: $35.87
High: $39.68

50 Day Range

MA: $33.14
Low: $27.33
High: $39.38

52 Week Range

Now: $39.38
Low: $26.49
High: $118.25

Volume

996,623 shs

Average Volume

749,994 shs

Market Capitalization

$2.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

Frequently Asked Questions

What sell-side analysts currently cover shares of Rapid7?

The following equities research analysts have issued research reports on Rapid7 in the last twelve months: Barclays PLC, Berenberg Bank, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., DA Davidson, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, StockNews.com, The Goldman Sachs Group, Inc., Truist Financial Co., William Blair, and Wolfe Research.
View the latest analyst ratings for RPD.

What is the current price target for Rapid7?

18 Wall Street analysts have set twelve-month price targets for Rapid7 in the last year. Their average twelve-month price target is $61.17, suggesting a possible upside of 55.3%. The Goldman Sachs Group, Inc. has the highest price target set, predicting RPD will reach $130.00 in the next twelve months. DA Davidson has the lowest price target set, forecasting a price of $34.00 for Rapid7 in the next year.
View the latest price targets for RPD.

What is the current consensus analyst rating for Rapid7?

Rapid7 currently has 11 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RPD, but not buy more shares or sell existing shares.
View the latest ratings for RPD.

What other companies compete with Rapid7?

How do I contact Rapid7's investor relations team?

Rapid7's physical mailing address is 120 Causeway Street, Boston MA, 02114. The technology company's listed phone number is (617) 247-1717 and its investor relations email address is [email protected] The official website for Rapid7 is www.rapid7.com. Learn More about contacing Rapid7 investor relations.